EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Seeking Alpha / 8 hours ago 1 Views
Seeking Alpha / 8 hours ago 1 Views
EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Comments